Gilead Sciences, Inc. (GILD)
137.21
-3.90
(-2.76%)
USD |
NASDAQ |
Mar 20, 16:00
136.61
-0.60
(-0.44%)
After-Hours: 20:00
Gilead Sciences Research and Development Expense (Quarterly) : 1.565B for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amgen, Inc. | 2.151B |
| Johnson & Johnson | 4.268B |
| Eli Lilly & Co. | 3.802B |
| Arcellx, Inc. | 34.10M |
| Moderna, Inc. | 708.00M |